title: Defining Glomerular Disease in Mechanistic Terms: Implementing an Integrative Biology Approach in Nephrology.
abstract: Advances in biomedical research allow for the capture of an unprecedented level of genetic, molecular, and clinical information from large patient cohorts, where the quest for precision medicine can be pursued. An overarching goal of precision medicine is to integrate the large-scale genetic and molecular data with deep phenotypic information to identify a new mechanistic disease classification. This classification can ideally be used to meet the clinical goal of the right medication for the right patient at the right time. Glomerular disease presents a formidable challenge for precision medicine. Patients present with similar signs and symptoms, which cross the current disease categories. The diseases are grouped by shared histopathologic features, but individual patients have dramatic variability in presentation, progression, and response to therapy, reflecting the underlying biologic heterogeneity within each glomerular disease category. Despite the clinical challenge, glomerular disease has several unique advantages to building multilayered datasets connecting genetic, molecular, and structural information needed to address the goals of precision medicine in this population. Kidney biopsy tissue, obtained during routine clinical care, provides a direct window into the molecular mechanisms active in the affected organ. In addition, urine is a biofluid ideally suited for repeated measurement from the diseased organ as a liquid biopsy with potential to reflect the dynamic state of renal tissue. In our review, current approaches for large-scale data generation and integration along the genotype-phenotype continuum in glomerular disease will be summarized. Several successful examples of this integrative biology approach within glomerular disease will be highlighted along with an outlook on how achieving a mechanistic disease classification could help to shape glomerular disease research and care in the future.
authors.affiliation: Division of Nephrology, University of Michigan Medical Center, Ann Arbor, Michigan; and.
authors.forename: Laura H
authors.initials: LH
authors.lastname: Mariani
authors.affiliation: Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina Kidney Center, Chapel Hill, North Carolina.
authors.forename: William F
authors.initials: WF
authors.lastname: Pendergraft
authors.affiliation: Division of Nephrology, University of Michigan Medical Center, Ann Arbor, Michigan; and.
authors.forename: Matthias
authors.initials: M
authors.lastname: Kretzler
mesh_terms: D019295:Computational Biology; D066264:Datasets as Topic; D057890:Epigenomics; D005838:Genotype; D006801:Humans; D007674:Kidney Diseases / Q000145:classification* / Q000188:drug therapy / Q000209:etiology / Q000235:genetics*; D007678:Kidney Glomerulus; D055432:Metabolomics; D064307:Microbiota; D010641:Phenotype; D040901:Proteomics; D059467:Transcriptome
keywords: Biological Products; Biology; Biomedical Research; Biopsy; Genotype; Goals; Humans; Kidney Glomerulus; Phenotype; Precision Medicine; genetics and development; glomerular disease; glomerulonephritis; glomerulopathy; molecular genetics; nephrology; transcriptional profiling